4//SEC Filing
Mack Gene 4
Accession 0001209191-18-025967
CIK 0001390478other
Filed
Apr 23, 8:00 PM ET
Accepted
Apr 24, 4:53 PM ET
Size
5.9 KB
Accession
0001209191-18-025967
Insider Transaction Report
Form 4
Mack Gene
CFO and Treasurer
Transactions
- Award
Stock Option (Right to Buy)
2018-04-20+40,000→ 40,000 totalExercise: $5.38Exp: 2028-04-19→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]One-quarter (1/4) of the option shares will vest and became exercisable one year from the April 20, 2018 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date.
Documents
Issuer
SELLAS Life Sciences Group, Inc.
CIK 0001390478
Entity typeother
Related Parties
1- filerCIK 0001737979
Filing Metadata
- Form type
- 4
- Filed
- Apr 23, 8:00 PM ET
- Accepted
- Apr 24, 4:53 PM ET
- Size
- 5.9 KB